
Keywords: CDAI، شاخص فعالیت بیماری کرون; Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; Drug development; Clinical trialsCD, Crohn's disease; CDAI, Crohn's Disease Activity Index; CRP, C-reactive protein; Fab, Fragment antigen-binding; GM-CSF, Granulocyte-Macrophage Colony-Stim